Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
12.39
-0.13 (-1.04%)
Dec 20, 2024, 4:00 PM EST - Market closed
Greenwich LifeSciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -10.5 | -8.89 | -7.83 | -4.57 | -1.86 | -3.43 | |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | |
| Stock-Based Compensation | 2.38 | 2.38 | 1.74 | 0.66 | 0.68 | 0.19 | |
| Other Operating Activities | - | - | - | - | - | -0 | |
| Change in Accounts Payable | 0.54 | 0.04 | - | -0.53 | -0.09 | 0.39 | |
| Change in Other Net Operating Assets | 0 | -0 | -0.12 | 0.14 | 0.12 | 2.54 | |
| Operating Cash Flow | -7.57 | -6.48 | -6.2 | -4.29 | -1.15 | -0.29 | |
| Short-Term Debt Issued | - | - | - | - | - | 0.22 | |
| Total Debt Issued | - | - | - | - | - | 0.22 | |
| Short-Term Debt Repaid | - | - | - | -0.28 | -0.36 | - | |
| Total Debt Repaid | - | - | - | -0.28 | -0.36 | - | |
| Net Debt Issued (Repaid) | - | - | - | -0.28 | -0.36 | 0.22 | |
| Issuance of Common Stock | 4.25 | - | - | 3.36 | 33.65 | - | |
| Repurchase of Common Stock | - | - | -7.54 | - | - | - | |
| Other Financing Activities | - | - | - | -0.25 | -3.48 | - | |
| Financing Cash Flow | 4.25 | - | -7.54 | 2.84 | 29.81 | 0.22 | |
| Net Cash Flow | -3.32 | -6.48 | -13.74 | -1.46 | 28.65 | -0.08 | |
| Free Cash Flow | -7.57 | -6.48 | -6.2 | -4.29 | -1.15 | -0.29 | |
| Free Cash Flow Per Share | -0.58 | -0.50 | -0.48 | -0.33 | -0.12 | -0.13 | |
| Levered Free Cash Flow | -3.8 | -3.42 | -3.4 | -2.59 | -0.45 | -1.51 | |
| Unlevered Free Cash Flow | -3.8 | -3.42 | -3.4 | -2.59 | -0.45 | -1.51 | |
| Change in Net Working Capital | -0.55 | -0.03 | 0.12 | 0.39 | -0.03 | -0.43 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.